InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PTC THERAPEUTICS, INC.

PTCT Clue Score78
United States Fiscal year ends December CIK 0001070081
$64.70 +3.42% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $64.70 +74.30% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue82.7Operating income−132.1Net income−142.1Fiscal year 2017Revenue194.4 +135.0%Operating income−64.3Net income−79.0Fiscal year 2018Revenue264.7 +36.2%Operating income−115.7Net income−128.1Fiscal year 2019Revenue307.0 +16.0%Operating income−241.2Net income−251.6EPS, diluted−4.27Fiscal year 2020Revenue380.8 +24.0%Operating income−431.8Net income−438.2EPS, diluted−6.64Fiscal year 2021Revenue538.6 +41.4%Operating income−374.4Net income−523.9EPS, diluted−7.43Fiscal year 2022Revenue698.8 +29.7%Operating income−447.4Net income−559.0EPS, diluted−7.79Fiscal year 2023Revenue937.8 +34.2%Operating income−439.5Net income−626.6EPS, diluted−8.37Fiscal year 2024Revenue806.8 −14.0%Operating income−302.6Net income−363.3EPS, diluted−4.73Fiscal year 2025Revenue1,730.7 +114.5%Operating income866.9Net income682.6EPS, diluted7.78
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 82.7 194.4 264.7 307.0 380.8 538.6 698.8 937.8 806.8 1,730.7
Growth +135.0% +36.2% +16.0% +24.0% +41.4% +29.7% +34.2% −14.0% +114.5%
Operating income −132.1 −64.3 −115.7 −241.2 −431.8 −374.4 −447.4 −439.5 −302.6 866.9
Net income −142.1 −79.0 −128.1 −251.6 −438.2 −523.9 −559.0 −626.6 −363.3 682.6
Growth
EPS, diluted n/a n/a n/a −4.27 −6.64 −7.43 −7.79 −8.37 −4.73 7.78
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−159.7%Net margin−171.8%Free cash flow margin−127.4%Fiscal year 2017Operating margin−33.1%Net margin−40.6%Free cash flow margin−6.8%Fiscal year 2018Operating margin−43.7%Net margin−48.4%Free cash flow margin−13.1%Fiscal year 2019Operating margin−78.6%Net margin−82.0%Free cash flow margin−36.6%Fiscal year 2020Operating margin−113.4%Net margin−115.1%Free cash flow margin−55.7%Fiscal year 2021Operating margin−69.5%Net margin−97.3%Free cash flow margin−51.9%Fiscal year 2022Operating margin−64.0%Net margin−80.0%Free cash flow margin−55.6%Fiscal year 2023Operating margin−46.9%Net margin−66.8%Free cash flow margin−19.9%Fiscal year 2024Operating margin−37.5%Net margin−45.0%Free cash flow margin−14.2%Fiscal year 2025Operating margin50.1%Net margin39.4%Free cash flow margin40.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −159.7% −33.1% −43.7% −78.6% −113.4% −69.5% −64.0% −46.9% −37.5% 50.1%
Net margin −171.8% −40.6% −48.4% −82.0% −115.1% −97.3% −80.0% −66.8% −45.0% 39.4%
Free cash flow margin −127.4% −6.8% −13.1% −36.6% −55.7% −51.9% −55.6% −19.9% −14.2% 40.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−103.6Capital expenditure−1.8Free cash flow−105.3Fiscal year 2017Operating cash flow−10.1Capital expenditure−3.1Free cash flow−13.2Fiscal year 2018Operating cash flow−27.6Capital expenditure−7.1Free cash flow−34.7Fiscal year 2019Operating cash flow−98.6Capital expenditure−13.8Free cash flow−112.4Fiscal year 2020Operating cash flow−194.1Capital expenditure−17.8Free cash flow−211.9Fiscal year 2021Operating cash flow−251.3Capital expenditure−28.2Free cash flow−279.5Fiscal year 2022Operating cash flow−356.7Capital expenditure−32.0Free cash flow−388.7Fiscal year 2023Operating cash flow−158.4Capital expenditure−28.4Free cash flow−186.9Fiscal year 2024Operating cash flow−107.7Capital expenditure−6.5Free cash flow−114.2Fiscal year 2025Operating cash flow711.2Capital expenditure−8.9Free cash flow702.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −103.6 −10.1 −27.6 −98.6 −194.1 −251.3 −356.7 −158.4 −107.7 711.2
Capital expenditure −1.8 −3.1 −7.1 −13.8 −17.8 −28.2 −32.0 −28.4 −6.5 −8.9
Free cash flow −105.3 −13.2 −34.7 −112.4 −211.9 −279.5 −388.7 −186.9 −114.2 702.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash58.3Total debt98.2Net cash (debt)−39.9Shareholders’ equity119.6Debt to equity0.82Fiscal year 2017Cash111.8Total debt145.0Net cash (debt)−33.2Shareholders’ equity156.4Debt to equity0.93Fiscal year 2018Cash169.5Total debt153.0Net cash (debt)16.5Shareholders’ equity350.7Debt to equity0.44Fiscal year 2019Cash288.0Total debt313.9Net cash (debt)−25.8Shareholders’ equity594.3Debt to equity0.53Fiscal year 2020Cash208.8Total debt309.1Net cash (debt)−100.3Shareholders’ equity482.0Debt to equity0.64Fiscal year 2021Cash189.7Total debt431.4Net cash (debt)−241.7Shareholders’ equity1.4Debt to equity300.02Fiscal year 2022Cash279.8Total debt571.7Net cash (debt)−291.9Shareholders’ equity−347.1Fiscal year 2023Cash594.0Total debt284.2Net cash (debt)309.8Shareholders’ equity−818.6Fiscal year 2024Cash779.7Total debt285.4Net cash (debt)494.3Shareholders’ equity−1,098.1Fiscal year 2025Cash984.6Total debt286.6Net cash (debt)698.0Shareholders’ equity−205.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 58.3 111.8 169.5 288.0 208.8 189.7 279.8 594.0 779.7 984.6
Total debt 98.2 145.0 153.0 313.9 309.1 431.4 571.7 284.2 285.4 286.6
Net cash (debt) −39.9 −33.2 16.5 −25.8 −100.3 −241.7 −291.9 309.8 494.3 698.0
Shareholders’ equity 119.6 156.4 350.7 594.3 482.0 1.4 −347.1 −818.6 −1,098.1 −205.3
Debt to equity 0.82 0.93 0.44 0.53 0.64 300.02 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−103.6 −10.1 −27.6 −98.6 −194.1 −251.3 −356.7 −158.4 −107.7 711.2
Growth
3.3 17.7 26.1 32.2 43.5 64.1 128.8 236.6 75.7 38.8
Investment
−1.8 −3.1 −7.1 −13.8 −17.8 −28.2 −32.0 −28.4 −6.5 −8.9
calc −105.3 −13.2 −34.7 −112.4 −211.9 −279.5 −388.7 −186.9 −114.2 702.3
Growth
calc n/a n/a n/a −1.91 −3.21 −3.97 −5.42 −2.50 −1.49 7.95
104.5 13.1 −42.6 −387.2 −561.5 219.2 290.2 −176.7 44.2 −862.0
Financing
1.0 44.2 131.6 613.2 668.7 20.9 168.0 646.4 255.9 331.1

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.